Clinical Trial Update: Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

View source ↗

Summary

The Resistell AG trial NCT05613322 evaluating the Resistell Phenotech AST for determining antibiotic susceptibility in Gram-negative bacteria causing bacteremia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Sepsis

Drugs mentioned

• Resistell Phenotech AST

Snippet

Sponsor: Resistell AG | Conditions: Bacteremia Sepsis | Status: TERMINATED